• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

准分子激光屈光性角膜切削术后12至55个月的角膜内皮状态

Corneal endothelial status 12 to 55 months after excimer laser photorefractive keratectomy.

作者信息

Mardelli P G, Piebenga L W, Matta C S, Hyde L L, Gira J

机构信息

University of Missouri-Kansas City School of Medicine, Department of Ophthalmology, Eye Foundation of Kansas City 64108, USA.

出版信息

Ophthalmology. 1995 Apr;102(4):544-9; discussion 548-9. doi: 10.1016/s0161-6420(95)30984-0.

DOI:10.1016/s0161-6420(95)30984-0
PMID:7724171
Abstract

PURPOSE

To investigate the long-term effect (range, 12-55 months) of photorefractive keratectomy (PRK) on the human corneal endothelium.

METHODS

Specular microscopy of the central corneal endothelium was performed on 106 patients who underwent PRK to correct myopia. The duration of follow-up varied from 12 to 55 months (mean, 33 months; median, 37 months). Patients were divided in two groups: group 1 included 32 patients (35 treated eyes) with preoperative and postoperative central endothelial images; group 2 included 26 patients from group 1 and 74 additional patients with postoperative central endothelial images of the treated and untreated fellow eyes.

RESULTS

In group 1, preoperative and postoperative values were as follows: mean cell density (+/- standard deviation), 2950 +/- 329 cells/mm2 and 2907 +/- 337 cells/mm2, respectively (P = 0.43); polymegathism index, 0.29 +/- 0.06 and 0.28 +/- 0.05, respectively (P = 0.38); pleomorphism index, 65.8% +/- 5.6% and 64.2% +/- 5.6%, respectively (P = 0.22); figure coefficient index, 0.86 +/- 0.05 and 0.87 +/- 0.02, respectively (P = 0.20). In group 2, postoperative values of the treated and untreated eyes were as follows: mean cell density, 2912 +/- 363 cells/mm2 and 2922 +/- 434 cells/mm2, respectively (P = 0.86); polymegathism index, 0.28 +/- 0.05 and 0.30 +/- 0.08, respectively (P = 0.04); pleomorphism index, 64.93% +/- 7.49% and 64.07% +/- 8.31%, respectively (P = 0.45); figure coefficient index, 0.88 +/- 0.03 and 0.88 +/- 0.03, respectively (P = 0.79).

CONCLUSIONS

Photorefractive keratectomy caused no damage to the central corneal endothelium. Polymegathism differences in treated and untreated eyes could be attributed to modifications in corneal metabolism or to a yet unknown mechanism.

摘要

目的

研究准分子激光角膜切削术(PRK)对人角膜内皮的长期影响(范围为12 - 55个月)。

方法

对106例行PRK矫正近视的患者进行中央角膜内皮的镜面反射显微镜检查。随访时间从12个月到55个月不等(平均33个月;中位数37个月)。患者分为两组:第1组包括32例患者(35只治疗眼),有术前和术后中央内皮图像;第2组包括第1组的26例患者以及另外74例有治疗眼和未治疗对侧眼术后中央内皮图像的患者。

结果

在第1组中,术前和术后的值如下:平均细胞密度(±标准差)分别为2950±329个细胞/mm²和2907±337个细胞/mm²(P = 0.43);大小不均一指数分别为0.29±0.06和0.28±0.05(P = 0.38);多形性指数分别为65.8%±5.6%和64.2%±5.6%(P = 0.22);形态系数指数分别为0.86±0.05和0.87±0.02(P = 0.20)。在第2组中,治疗眼和未治疗眼的术后值如下:平均细胞密度分别为2912±363个细胞/mm²和2922±434个细胞/mm²(P = 0.86);大小不均一指数分别为0.28±0.05和0.30±0.08(P = 0.04);多形性指数分别为64.93%±7.49%和64.07%±8.31%(P = 0.45);形态系数指数分别为0.88±0.03和0.88±0.03(P = 0.79)。

结论

准分子激光角膜切削术未对中央角膜内皮造成损伤。治疗眼和未治疗眼之间大小不均一性的差异可能归因于角膜代谢的改变或一种尚不清楚的机制。

相似文献

1
Corneal endothelial status 12 to 55 months after excimer laser photorefractive keratectomy.准分子激光屈光性角膜切削术后12至55个月的角膜内皮状态
Ophthalmology. 1995 Apr;102(4):544-9; discussion 548-9. doi: 10.1016/s0161-6420(95)30984-0.
2
Specular microscopy of the corneal endothelium after excimer laser photorefractive keratectomy.
J Cataract Refract Surg. 1996 Mar;22(2):188-93. doi: 10.1016/s0886-3350(96)80217-3.
3
Short-term corneal endothelial changes after photorefractive keratectomy.准分子激光原位角膜磨镶术后短期角膜内皮变化。
J Refract Corneal Surg. 1994 Mar-Apr;10(2 Suppl):S194-8.
4
Corneal endothelial changes after excimer laser photorefractive keratectomy.
Am J Ophthalmol. 1993 Dec 15;116(6):692-4. doi: 10.1016/s0002-9394(14)73467-1.
5
Excimer laser in situ keratomileusis and photorefractive keratectomy for correction of high myopia.准分子激光原位角膜磨镶术和准分子激光角膜切削术治疗高度近视。
J Refract Corneal Surg. 1994 Sep-Oct;10(5):498-510.
6
The effect of photorefractive keratectomy on the corneal endothelium.准分子激光原位角膜磨镶术对角膜内皮的影响。
Ophthalmology. 1996 Sep;103(9):1357-65. doi: 10.1016/s0161-6420(96)30496-x.
7
The corneal endothelium after myopic excimer laser photorefractive keratectomy.准分子激光原位角膜磨镶术后的角膜内皮
Arch Ophthalmol. 1994 Jul;112(7):920-4. doi: 10.1001/archopht.1994.01090190068023.
8
Endothelial cells evaluation two years after photorefractive keratectomy.准分子激光原位角膜磨镶术后两年的内皮细胞评估
Ophthalmologica. 1997;211(1):32-9. doi: 10.1159/000310871.
9
Endothelial cell loss after photorefractive keratectomy for myopia.
Acta Ophthalmol Scand. 1998 Jun;76(3):304-7. doi: 10.1034/j.1600-0420.1998.760310.x.
10
The human corneal endothelium after myopic excimer laser photorefractive keratectomy immediate to one-month follow-up.
Eur J Ophthalmol. 1995 Oct-Dec;5(4):204-13. doi: 10.1177/112067219500500402.

引用本文的文献

1
Clinical Evaluation of Corneal Endothelial Parameters following Laser Refractive Surgery in Myopic Eyes: A Review.近视眼激光屈光手术后角膜内皮参数的临床评估:综述
J Clin Med. 2024 Mar 14;13(6):1665. doi: 10.3390/jcm13061665.
2
Clearing the Haze: Navigating Corneal Refractive Surgery in Patients with Posterior Polymorphous Corneal Dystrophy.拨开迷雾:后极性多形性角膜营养不良患者的角膜屈光手术导航
Ophthalmol Ther. 2021 Sep;10(3):383-387. doi: 10.1007/s40123-021-00364-z. Epub 2021 Jun 24.
3
Corneal Regeneration After Photorefractive Keratectomy: A Review.
准分子激光原位角膜磨镶术后的角膜再生:综述
J Optom. 2015 Jul-Sep;8(3):149-69. doi: 10.1016/j.optom.2014.09.001. Epub 2014 Oct 23.
4
Corneal endothelial cell loss 9 years after excimer laser keratorefractive surgery.准分子激光角膜屈光手术后9年的角膜内皮细胞丢失
Arch Ophthalmol. 2009 Nov;127(11):1423-7. doi: 10.1001/archophthalmol.2009.192.
5
Confocal microscopy reveals persisting stromal changes after myopic photorefractive keratectomy in zero haze corneas.共聚焦显微镜检查显示,在零 haze 角膜的近视性屈光性角膜切削术后,基质变化持续存在。
Br J Ophthalmol. 1998 Dec;82(12):1393-400. doi: 10.1136/bjo.82.12.1393.
6
Topical aldose reductase inhibitor.局部用醛糖还原酶抑制剂。
Br J Ophthalmol. 1995 Dec;79(12):1064-5. doi: 10.1136/bjo.79.12.1064.